Microbotox: A prospective evaluation of dermatological improvement in patients with mild‐to‐moderate acne and erythematotelangiectatic rosacea
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cosmetic Dermatology"
DOI: 10.1111/jocd.14692
Abstract: Botulin toxin (BTX) is a potent neurotoxin produced by the bacterium Clostridium botulinum, since its approval by FDA in 2002 for cosmetic purpose has been widely used. Recent studies indicate that it exerts its activity… read more here.
Keywords: evaluation dermatological; dermatological improvement; microbotox prospective; improvement patients ... See more keywords